A Trial to Determine the Maximum Tolerated Dose and Evaluate the Safety and Pharmacokinetics of Docetaxel-PNP, Polymeric Nanoparticle Formulation of Docetaxel, in Subjects With Advanced Solid Malignancies
Clinical trial NCT01103791 · COMPLETED
Trial details
- NCT number
- NCT01103791
- Sponsor
- Samyang Biopharmaceuticals Corporation
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-04-01
- Primary completion
- 2011-09-01
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.